Cell-type specific modulation of NMDA receptors triggers antidepressant actions
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“observed an increase in NMDAR-mediated currents in mouse layer 5 mPFC pyramidal neurons following rapastinel (0.1 but not 1.0 or 10 μM) treatment which required GluN2B expression in the pyramidal neurons (Pothula et al., 2020).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Pothula et al., 2020
In the citing paper
“rapastinel (1 mg/kg) produced antidepressant-like effects in the forced swim (24 hours post-treatment), female urine sniffing (72 hours post-treatment), and novelty suppressed feeding tests (96 hours post-treatment).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Pothula et al., 2020
In the citing paper
“When GluN2B was knocked down in GABAergic interneurons, the antidepressant-like effects of rapastinel were maintained in the forced swim, female urine sniffing, and novelty suppressed feeding tests, whereas ketamine was unable to produce an effect in the forced swim test.”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Pothula et al., 2020
In the citing paper
“The behavioral effects of rapastinel were prevented by knockdown of GluN2B in pyramidal neurons, whereas this manipulation did not impact the ability of ketamine (10 mg/kg i.p.) to elicit antidepressant-like effects in the forced swim test.”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Pothula et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“low rates of response and remission, and a significant subpopulation of depressed patients considered treatment resistant [2, 3].”
BackgroundAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 1×
“We target GluN2B, one of the major NMDAR subunits expressed on both inhibitory and excitatory neurons in mPFC, as preclinical and clinical studies have reported that selective GluN2B antagonists produce rapid antidepressant effects [11, 18].”
BackgroundSelf-citationMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · cited 5×
“Here we confirm that ketamine produces a rapid, but transient increase in extracellular glutamate release in mPFC [14] and also provide evidence that rapastinel, at doses which produce an antidepressant-like response in rodents, has no effect on extracellular glutamate.”
BackgroundInfluentialEpidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4602 · Cited by 1,737 · cited 1×
“devastating personal and economic consequences, and is a leading cause of disability world-wide [1].”
BackgroundDiagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380 · cited 1×
“low rates of response and remission, and a significant subpopulation of depressed patients considered treatment resistant [2, 3].”
BackgroundHomayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons
Chaudhury, D., Walsh, J. J., Friedman, A. K., Juarez, B., Ku, S. M., Koo, J. W., Ferguson, D., Tsai, H.-C., Pomeranz, L., Christoffel, D. J., et al. (2013) · Nature · doi:10.1038/nature11713 · Cited by 1,156 · cited 1×
“implicated in depression [45], via disinhibition in mPFC and rapastinel could directly activate these projections (Fig.”
BackgroundMorgan, C. J. A., Curran, H. V., & the Independent Scientific Committee on Drugs (ISCD) (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03576.x · Cited by 667
Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-053013-062946 · Cited by 422 · cited 1×
“depression, including difficult to treat and suicidal patients [4, 5].”
BackgroundSelf-citation
Research works printed but not linked: 26
- Sleigh J, Harvey M, Voss L, Denny B. Ketamine—more mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014;4:76–81. · DOI · Paper page
- Moskal JR, Burch R, Burgdorf JS, Kroes RA, Stanton PK, Disterhoft JF, et al. GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists. Expert Opin Investig Drugs. 2014;23:243–54. · DOI · Paper page
- Burch R, Preskorn S, Bastin L, Yu W, Burgdorf J, Moskal J. Adjunctive GLYX-13 induces prolonged efficacy in subjects with major depressive disorder (MDD). Neuropsychopharmacology. 2014;39:S335.
- Preskorn S, Macaluso M, Mehra DO, Zammit G, Moskal JR, Burch RM, et al. Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent. J Psychiatr Pract. 2015;21:140–9. · DOI · Paper page
- Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience. 2003;117:697–706. · DOI · Paper page
- Preskorn S, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-Methyl-D-Aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J Clin Psychopharmacol. 2008;28:631–7. · DOI · Paper page
- Yang CR, Seamans JK, Gorelova N. Electrophysiological and morphological properties of layers V-VI principal pyramidal cells in rat prefrontal cortex in vitro. J Neurosci. 1996;16:1904–21. · DOI · Paper page
- Wei X, Ma T, Cheng Y, Huang CCY, Wang X, Lu J, et al. Dopamine D1 or D2 receptor-expressing neurons in the central nervous system. Addict Biol. 2018;23:569–84. · DOI · Paper page
- Anastasiades PG, Boada C, Carter AG. Cell-Type-Specific D1 dopamine receptor modulation of projection neurons and interneurons in the prefrontal cortex. Cereb Cortex 2018;29:3224–42. · DOI · Paper page
- Kehr J, Yoshitake T. Monitoring brain chemical signals by microdialysis. In: Grimes CA, Dickey EC, Pishko MV, editors. Encyclopedia of sensors, Vol. 6. USA: American Scientific Publishers; 2006. p. 287–312.
- Kehr J, Yoshitake T. Derivatization chemistries for improved detection of monoamine neurotransmitters and their metabolites in microdialysis samples by liquid chromatography with fluorescence detection and mass spectrometry. In: Wilson G, Michael A, editors. Compendium of in-vivo monitoring in real-time molecular neuroscience, Vol. 2, microdialysis and sensing of neural tissues. Singapore: World Scientific Publishing; 2017. p. 193–216. · DOI
- Shinohara R, Taniguchi M, Ehrlich AT, Yokogawa K, Deguchi Y, Cherasse Y, et al. Dopamine D1 receptor subtype mediates acute stress-induced dendritic growth in excitatory neurons of the medial prefrontal cortex and contributes to suppression of stress susceptibility in mice. Mol Psychiatry. 2018;23:1717–30. · DOI
- Duman RS, Shinohara R, Fogaça MV, Hare B. Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function. Mol Psychiatry. 2019;24:1816–32. · DOI · Paper page
- White PF, Schüttler J, Shafer A, Stanski DR, Horai Y, Trevor AJ. Comparative pharmacology of the ketamine isomers: studies in volunteers. Br J Anaesth. 1985;57:197–203. · DOI · Paper page
- Tanaka K, Furuyashiki T, Kitaoka S, Senzai Y, Imoto Y, Segi-Nishida E, et al. Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social defeat stress in mice. J Neurosci. 2012;32:4319–29. · DOI · Paper page
- Anderson EM, Gomez D, Caccamise A, McPhail D, Hearing M. Chronic unpredictable stress promotes cell-specific plasticity in prefrontal cortex D1 and D2 pyramidal neurons. Neurobiol Stress. 2019;10:100152. · DOI · Paper page
- Miller OH, Bruns A, Ben Ammar I, Mueggler T, Hall BJ. Synaptic regulation of a thalamocortical circuit controls depression-related behavior. Cell Rep. 2017;20:1867–80. · DOI · Paper page
- Nowak G, Ordway GA, Paul IA. Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res. 1995;675:157–64. · DOI · Paper page
- Land BB, Narayanan NS, Liu RJ, Gianessi CA, Brayton CE, Grimaldi D, et al. Medial prefrontal D1 dopamine neurons control food intake. Nat Neurosci. 2014;17:248–53. · DOI · Paper page
- Gao C, Wolf ME. Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons. J Neurochem. 2008;106:2489–501. · DOI · Paper page
- Lavin A, Grace AA. Stimulation of D1-type dopamine receptors enhances excitability in prefrontal cortical pyramidal neurons in a state-dependent manner. Neuroscience. 2001;104:335–46. · DOI
- Gurden H, Takita M, Jay TM. Essential role of D1 but not D2 receptors in the NMDA receptor‐dependent long‐term potentiation at hippocampal‐prefrontal cortex synapses in vivo. J Neurosci. 2000;20:RC106. · DOI · Paper page
- Jay TM. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog Neurobiol. 2003;69:375–90. · DOI · Paper page
- Berry A, Bellisario V, Capoccia S, Tirassa P, Calza A, Alleva E, et al. Social deprivation stress is a triggering factor for the emergence of anxiety- and depression-like behaviours and leads to reduced brain BDNF levels in C57BL/6J mice. Psychoneuroendocrinology. 2012;37:762–72. · DOI · Paper page
- Ieraci A, Mallei A, Popoli M. Social isolation stress induces anxious-depressive-like behavior and alterations of neuroplasticity-related genes in adult male mice. Neural Plast. 2016;2016:6212983. · DOI · Paper page
- Haj-Mirzaian A, Amini-Khoei H, Haj-Mirzaian A, Amiri S, Ghesmati M, Zahir M, et al. Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model of social isolation stress. Brain Res Bull. 2017;130:200–10. · DOI
Cited by
Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action
Castrén, E., & Monteggia, L. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.008 · Cited by 540
Ketamine and rapid antidepressant action: New treatments and novel synaptic signaling mechanisms
Krystal, J. H., Kavalali, E. T., & Monteggia, L. M. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-023-01629-w · Cited by 262
The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
Sanacora, G., Yan, Z., & Popoli, M. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00540-x · Cited by 197
Self-citationMechanisms of ketamine and its metabolites as antidepressants
Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 175
Fogaça, M. V., Wu, M., Li, C., Li, X.-Y., Picciotto, M. R., & Duman, R. S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00916-y · Cited by 129
Self-citation
Metadata
- Authors
- Pothula, S., Kato, T., Liu, R.-J., Wu, M., Gerhard, D., Shinohara, R., Sliby, A.-N., Chowdhury, G. M. I., Behar, K. L., Sanacora, G., Banerjee, P., & Duman, R. S.
- Venue
- Molecular Psychiatry
- Published
- 2020-06-02
- Volume
- 26
- Issue
- 9
- Pages
- 5097-5111
- ISSN
- 1359-4184
- 1476-5578
- Cited by
- 81
- References
- 27
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH093897, MH105910)
- Allergan
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cell-type specific modulation of NMDA receptors triggers antidepressant actions. https://app.cochat.ai/papers/10.1038/s41380-020-0796-3
- The paper
- Pothula, S., Kato, T., Liu, R.-J., Wu, M., Gerhard, D., Shinohara, R., Sliby, A.-N., Chowdhury, G. M. I., Behar, K. L., Sanacora, G., Banerjee, P., & Duman, R. S. (2021). Cell-type specific modulation of NMDA receptors triggers antidepressant actions. Molecular Psychiatry. https://doi.org/10.1038/s41380-020-0796-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.